City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States and a top ...

Scientists have made a potentially “life-changing” discovery that could pave the way for new drugs to treat Parkinson’s disease. Experts have known for several decades that the PINK1 protein ...

Fred Hutch virologist Keith Jerome, MD, PhD, and evolutionary biologist Jesse Bloom, PhD, were recently elected to the 2025 ...

Oranges are a citrus fruit known for their immune-boosting properties, due to their high vitamin C content. However, there ...

Vitamins have been a part of our lives for generations, haven't they? From the bright orange chewable vitamin C tablets of childhood to the little capsules tucked into kitchen cabinets, they've always ...

In April 2024, Barinthus Bio announced topline results from the Phase 1b/2 APOLLO dose-ranging trial (also known as HPV001) ...

Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, potentially curative immunotherapy for celiac disease (VTP-1 ...

The debut of synthetic biological intelligence marks an unprecedented milestone in the fields of biotechnology and artificial intelligence (AI). Researchers ...

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...

New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without introducing deleterious mutations.

Imagine a previously unknown bug—new to our immune defenses—that suddenly emerged and rapidly spread all over the globe, ...